Feasibility of adjuvant S-1 plus docetaxel against stage II-III gastric cancer following R0 resection in gastrectomy

被引：1
|
作者：
Emi, Y. [1 ]
Orita, H. [2 ]
Yamamoto, M. [3 ,4 ]
Sadanaga, T. [5 ]
Kusumoto, T. [6 ]
Takahashi, I. [7 ]
Kakeji, Y. [1 ]
Maehara, Y. [1 ]
机构：
[1] Kyushu Univ, Grad Sch Med Sci, Fukuoka 812, Japan
[2] Saiseikai Yahate Gen Hosp, Kitakyushu, Fukuoka, Japan
[3] Hiroshima Red Cross Hosp, Hiroshima, Japan
[4] Atom Bomb Survivors Hosp, Hiroshima, Japan
[5] Saiseikai Fukuoka Gen Hosp, Fukuoka, Japan
[6] Natl Beppu Med Ctr, Beppu, Oita, Japan
[7] Matsuyama Red Cross Hosp, Matsuyama, Ehime, Japan
来源：
EJC SUPPLEMENTS | 2009年 / 7卷 / 02期
关键词：
D O I：
10.1016/S1359-6349(09)71258-3
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：372 / 372
页数：1
相关论文
共 50 条
  • [21] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer
    Takahari, Daisuke
    Hamaguchi, Tetsuya
    Yoshimura, Kenichi
    Katai, Hitoshi
    Ito, Seiji
    Fuse, Nozomu
    Konishi, Masaru
    Yasui, Hirofumi
    Terashima, Masanori
    Goto, Masahiro
    Tanigawa, Nobuhiko
    Shirao, Kuniaki
    Sano, Takeshi
    Sasako, Mitsuru
    GASTRIC CANCER, 2014, 17 (02) : 383 - 386
  • [22] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer
    Daisuke Takahari
    Tetsuya Hamaguchi
    Kenichi Yoshimura
    Hitoshi Katai
    Seiji Ito
    Nozomu Fuse
    Masaru Konishi
    Hirofumi Yasui
    Masanori Terashima
    Masahiro Goto
    Nobuhiko Tanigawa
    Kuniaki Shirao
    Takeshi Sano
    Mitsuru Sasako
    Gastric Cancer, 2014, 17 : 383 - 386
  • [23] Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
    Yu, Yuanyuan
    Zhang, Zicheng
    Meng, Qianhao
    Ma, Yue
    Fan, Xiaona
    Sun, Jie
    Wang, Guangyu
    FRONTIERS IN ONCOLOGY, 2021, 11
  • [24] Adjuvant Chemoradiotherapy Versus Adjuvant Chemotherapy for Stage III Gastric or Gastroesophageal Junction Cancer After D2/R0 Resection
    Shi, Jinming
    Kang, Wenzhe
    Tang, Yuan
    Li, Ning
    Jiang, Liming
    Yang, Lin
    Wang, Shulian
    Song, Yongwen
    Liu, Yueping
    Fang, Hui
    Lu, Ningning
    Qi, Shunan
    Chen, Bo
    Li, Yexiong
    Tian, Yantao
    Jin, Jing
    FRONTIERS IN ONCOLOGY, 2022, 12
  • [25] Phase II feasibility study of adjuvant S-1 plus CPT-11 for stage III gastric cancer patients after curative D2 gastrectomy (OGSG 0801).
    Kimura, Yutaka
    Fujitani, Kazumasa
    Ueda, Shugo
    Taniguchi, Hirokazu
    Imamura, Hiroshi
    Gofuku, Junji
    Tamura, Shigeyuki
    Kurokawa, Yukinori
    Takiuchi, Hiroya
    Furukawa, Hiroshi
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [26] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    D. Takahari
    T. Hamaguchi
    K. Yoshimura
    H. Katai
    S. Ito
    N. Fuse
    T. Kinoshita
    H. Yasui
    M. Terashima
    M. Goto
    N. Tanigawa
    K. Shirao
    T. Sano
    M. Sasako
    Cancer Chemotherapy and Pharmacology, 2011, 67 : 1423 - 1428
  • [27] PRODIGY: A Phase III Study of Neoadjuvant Docetaxel, Oxaliplatin, and S-1 Plus Surgery and Adjuvant S-1 Versus Surgery and Adjuvant S-1 for Resectable Advanced Gastric Cancer
    Kang, Yoon-Koo
    Yook, Jeong Hwan
    Park, Young-Kyu
    Lee, Jong Seok
    Kim, Young-Woo
    Kim, Jin Young
    Ryu, Min-Hee
    Rha, Sun Young
    Chung, Ik Joo
    Kim, In-Ho
    Oh, Sang Cheul
    Park, Young Soo
    Son, Taeil
    Jung, Mi Ran
    Heo, Mi Hwa
    Kim, Hark Kyun
    Park, ChoHyun
    Yoo, Chang Hak
    Choi, Jin-Hyuk
    Zang, Dae Young
    Jang, You Jin
    Sul, Ji Young
    Kim, Jong Gwang
    Kim, Beom Su
    Beom, Seung-Hoon
    Cho, Sang Hee
    Ryu, Seung Wan
    Kook, Myeong-Cherl
    Ryoo, Baek-Yeol
    Kim, Hyun Ki
    Yoo, Moon-Won
    Lee, Nam Su
    Lee, Sang Ho
    Kim, Gyunji
    Lee, YeonJu
    Lee, Jee Hyun
    Noh, Sung Hoon
    JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (26) : 2903 - +
  • [28] Feasibility study of adjuvant chemotherapy with S-1 plus cisplatin for gastric cancer
    Takahari, D.
    Hamaguchi, T.
    Yoshimura, K.
    Katai, H.
    Ito, S.
    Fuse, N.
    Kinoshita, T.
    Yasui, H.
    Terashima, M.
    Goto, M.
    Tanigawa, N.
    Shirao, K.
    Sano, T.
    Sasako, M.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 67 (06) : 1423 - 1428
  • [29] Survival analysis of adjuvant chemotherapy with S-1 plus cisplatin for stage III gastric cancer.
    Takahari, Daisuke
    Hamaguchi, Tetsuya
    Yoshimura, Kenichi
    Katai, Hitoshi
    Ito, Seiji
    Fuse, Nozomu
    Kinoshita, Taira
    Yasui, Hirofumi
    Terashima, Masanori
    Gotoh, Masahiro
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [30] A Phase I/II Study of NAC with Docetaxel, Cisplatin, and S-1 for Stage III Gastric Cancer
    Tanaka, Yusaku
    Kunisaki, Chikara
    Izumisawa, Yusuke
    Makino, Hirochika
    Kimura, Jun
    Sato, Sho
    Miyamoto, Hiroshi
    Kosaka, Takashi
    Ono, Hidetaka A.
    Takahashi, Masazumi
    Sato, Kei
    Akiyama, Hirotoshi
    Endo, Itaru
    ANTICANCER RESEARCH, 2018, 38 (10) : 6015 - 6021
12345